Pharma Journalist -

SGS announced that it is investing €3.5 million to undertake a two-phase expansion project at its laboratory in Poitiers, France, to implement a 50% increase in bioanalytical…
Read More...

WuXi AppTec announces the expansion of its facilities in San Diego, California. WuXi AppTec's newly expanded facility will establish a center of excellence in screening, discovery…
Read More...

HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Mitsubishi Tanabe Pharma Corporation to identify novel small molecule leads for…
Read More...

GeneCentric Therapeutics announced that it has entered into a research collaboration with the University of North Carolina at Chapel Hill (UNC) to assess patient response to…
Read More...

WuXi Biologics and Oxford BioTherapeutics announced the expansion of their strategic and innovative immuno-oncology (IO) alliance through which OBT will research, develop and…
Read More...

Gilead Sciences announced that its Board of Directors has named Daniel O’Day Chairman of the Board and Chief Executive Officer, effective March 1, 2019. Mr. O’Day is currently the CEO…
Read More...

AstraZeneca announced a new collaboration with Cancer Research UK to launch a centre of excellence in genetic screening, cancer modelling and big data processing aimed at accelerating…
Read More...

Bristol-Myers Squibb Company and Vedanta Biosciences announced a clinical trial collaboration to evaluate Bristol-Myers Squibb's programmed death-1 (PD-1) immune checkpoint inhibitor…
Read More...

Pharmaceutical Product Development, LLC (PPD) is adding gene and cell therapy analytical testing to its GMP (good manufacturing practices) laboratory in Athlone, Ireland, to support the…
Read More...

Merck KGaA, Darmstadt, Germany announced that it has entered into a licensing agreement with Cyclica Inc. for the use of Ligand Express, a cloud-based in silico proteome screening…
Read More...